» Articles » PMID: 28543357

Associations of TNF-α -238 A/G and IL-10 -1082 G/A Genetic Polymorphisms With the Risk of NONFH in the Chinese Population

Overview
Journal J Cell Biochem
Date 2017 May 26
PMID 28543357
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The study aims to explore the roles of common polymorphisms of Tumor Necrosis Factor-α (TNF-α) (-238 A/G and -308 A/G) and IL-10 (-819 T/C and -1082 G/A) genes in the risk of non-traumatic osteonecrosis of the femoral head (NONFH). One hundred and forty-seven NONFH patients and 135 healthy individuals were selected as the case and control groups. qRT-PCR and Western blotting techniques detected mRNA as well as protein expressions of TNF-α and IL-10 of each genotype in both the case and control groups. The GA genotype and the A allele of TNF-α -238 A/G were higher in the case group than in the control group. Compared with the control group, AA, GA, and AG + AA genotypes as well as the A allele of IL-10-1082 G/A were all lower in the case group. In the case groups increased levels of TNF-α as well as decreased levels of IL-10 expression when compared with the control group. TNF-α expression of TNF-α-238 GA genotype was significantly higher than that in patients with GG genotype, while the IL-10 expression of GA and AA genotypes of IL-10-1082 was significantly lower than in that of patients with the GG genotype. TNF-α protein expression in the GA genotype was significantly higher than in the GG genotype. In relation to TNF-α -238, TNF-α protein expression of GA and AA genotypes had significantly reduced more so than the GG genotype in IL-10-1082. TNF-α-238 A/G and IL-10-1082 G/A may be involved as risk factors of NONFH. J. Cell. Biochem. 118: 4872-4880, 2017. © 2017 Wiley Periodicals, Inc.

Citing Articles

DNA methylation in the OPG/RANK/RANKL pathway is associated with steroid-induced osteonecrosis of the femoral head.

Sun M, Cao Y, Yang X, An F, Wu H, Wang J BMC Musculoskelet Disord. 2021; 22(1):599.

PMID: 34187427 PMC: 8240366. DOI: 10.1186/s12891-021-04472-6.


Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation.

Partanen J, Hyvarinen K, Bickeboller H, Bogunia-Kubik K, Crossland R, Ivanova M Front Immunol. 2020; 11:575492.

PMID: 33193367 PMC: 7604383. DOI: 10.3389/fimmu.2020.575492.


No association between three polymorphisms (rs1800629, rs361525 and rs1799724) in the tumor necrosis factor-α gene and susceptibility to prostate cancer: a comprehensive meta-analysis.

Yin L, Yue C, Jing H, Yu H, Zuo L, Liu T Hereditas. 2020; 157(1):11.

PMID: 32264962 PMC: 7137332. DOI: 10.1186/s41065-020-00125-1.


Involvement of tumor necrosis factor alpha in steroid-associated osteonecrosis of the femoral head: friend or foe?.

Fang B, Wang D, Zheng J, Wei Q, Zhan D, Liu Y Stem Cell Res Ther. 2019; 10(1):5.

PMID: 30606261 PMC: 6318982. DOI: 10.1186/s13287-018-1112-x.


Genetic polymorphisms in tumor necrosis factor alpha and interleukin-10 are associated with an increased risk of cervical cancer.

Du G, Wang J, Richards J, Wang J Int Immunopharmacol. 2018; 66:154-161.

PMID: 30453149 PMC: 6348885. DOI: 10.1016/j.intimp.2018.11.015.